-
1
المؤلفون: James Larkin, Jeffrey S. Weber, F. Stephen Hodi, Paolo A. Ascierto, Roger Olofsson Bagge, Georgina V. Long, Alexander C.J. van Akkooi, Jacob Schachter, Caroline Robert, Lars Ny
المصدر: Melanoma Research. 31:181-185
مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Ipilimumab, Dermatology, Pembrolizumab, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Clinical endpoint, Humans, Medicine, Neoplasm Metastasis, Stage (cooking), Melanoma, Randomized Controlled Trials as Topic, business.industry, medicine.disease, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, Female, Immunotherapy, Nivolumab, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3a480cb93e62763c98a1eb0a61f5b12Test
https://doi.org/10.1097/cmr.0000000000000719Test -
2
المؤلفون: Lars Bastholt, Ivan Marquez Rodas, Jochen Utikal, Pier Francesco Ferrucci, Harriet Tuson, Luc Thomas, Miranda Payne, Pascal Wolter, Caroline Robert, J McKendrick, Johan Hansson, Paolo A. Ascierto, Amber Kudlac
المصدر: Melanoma Research
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Ascierto, P A, Bastholt, L, Ferrucci, P F, Hansson, J, Márquez Rodas, I, Payne, M, Robert, C, Thomas, L, Utikal, J S, Wolter, P, Kudlac, A, Tuson, H & McKendrick, J 2018, ' The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma : Results from a European expert panel study ', Melanoma Research, vol. 28, no. 4, pp. 333-340 . https://doi.org/10.1097/CMR.0000000000000455Testمصطلحات موضوعية: Disease specific, Male, Proto-Oncogene Proteins B-raf, advanced melanoma, Cancer Research, medicine.medical_specialty, Skin Neoplasms, BRAF/MEK inhibitors, medicine.medical_treatment, Delphi method, Patient characteristics, Dermatology, Targeted therapy, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Surveys and Questionnaires, medicine, Humans, Intensive care medicine, Melanoma, Advanced melanoma, business.industry, factors, selecting therapy, medicine.disease, ORIGINAL ARTICLES: Clinical research, expert opinion, First line treatment, Europe, Oncology, first-line treatment decision, 030220 oncology & carcinogenesis, ComputingMethodologies_DOCUMENTANDTEXTPROCESSING, Female, Treatment decision making, immunotherapy, business, checkpoint inhibitors
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee4e9e62e780a228a3f3cccf6e9e120Test
https://pubmed.ncbi.nlm.nih.gov/29750751Test -
3
المؤلفون: Samy Ammari, Salima Hibat-Allah, Frédéric Dhermain, Mathieu Texier, Charlée Nardin, Caroline Robert, Christine Mateus, Emilie Lanoy
المصدر: Melanoma research. 28(2)
مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Population, Ipilimumab, Dermatology, Pembrolizumab, Antibodies, Monoclonal, Humanized, Radiosurgery, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, parasitic diseases, Clinical endpoint, Medicine, Humans, Neoplasm Metastasis, Prospective cohort study, education, Aged, Retrospective Studies, Aged, 80 and over, education.field_of_study, business.industry, Brain Neoplasms, Melanoma, Chemoradiotherapy, Middle Aged, medicine.disease, 030104 developmental biology, Treatment Outcome, 030220 oncology & carcinogenesis, Female, Nivolumab, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf47e8d5161bd7b7d968441998e4af3eTest
https://pubmed.ncbi.nlm.nih.gov/29356789Test